Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.500
+0.070 (1.58%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Y-mAbs Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Market Capitalization
2033512972137072,006
Upgrade
Market Cap Growth
17.88%17.88%39.61%-69.88%-64.73%61.56%
Upgrade
Enterprise Value
1372842131014941,879
Upgrade
Last Close Price
4.507.836.824.8816.2149.51
Upgrade
PS Ratio
2.274.003.513.2720.2796.67
Upgrade
PB Ratio
2.203.812.951.953.9318.95
Upgrade
P/TBV Ratio
3.913.913.032.013.9718.95
Upgrade
EV/Sales Ratio
1.563.242.511.5414.1690.55
Upgrade
Debt / Equity Ratio
0.010.010.010.020.020.04
Upgrade
Asset Turnover
0.710.710.630.370.200.12
Upgrade
Inventory Turnover
2.482.481.941.24--
Upgrade
Quick Ratio
3.673.675.024.186.795.87
Upgrade
Current Ratio
4.164.165.524.617.266.26
Upgrade
Return on Equity (ROE)
-30.74%-30.74%-20.39%-66.06%-38.66%-78.32%
Upgrade
Return on Assets (ROA)
-12.67%-12.67%-9.84%-29.40%-41.84%-43.03%
Upgrade
Return on Capital (ROIC)
-16.08%-16.08%-12.41%-35.34%-49.15%-48.21%
Upgrade
Earnings Yield
-14.58%-8.46%-7.20%-44.85%-7.81%-5.95%
Upgrade
FCF Yield
-7.72%-4.48%-9.15%-35.63%-14.59%-4.56%
Upgrade
Buyback Yield / Dilution
-1.57%-1.57%0.13%-1.21%-7.64%-14.03%
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q